Provided by Tiger Fintech (Singapore) Pte. Ltd.

Natera

148.08
-2.0900-1.39%
Post-market: 148.080.00000.00%17:54 EDT
Volume:602.61K
Turnover:89.46M
Market Cap:20.02B
PE:-96.98
High:150.09
Open:150.09
Low:147.13
Close:150.17
Loading ...

Natera Inc : Guggenheim Raises Target Price to $170 From $165

THOMSON REUTERS
·
16 Dec 2024

Natera Is Maintained at Overweight by JP Morgan

Dow Jones
·
13 Dec 2024

Natera price target raised to $200 from $160 at JPMorgan

TIPRANKS
·
13 Dec 2024

Natera Inc : JP Morgan Raises Target Price to $200 From $160

THOMSON REUTERS
·
13 Dec 2024

BRIEF-Natera Announces Enrollment Of First Patients In Sagittarius: A Randomized, Phase III Clinical Trial In Colon Cancer

Reuters
·
12 Dec 2024

Natera Inc - 700-900 Patients Expected to Be Enrolled in Trial

THOMSON REUTERS
·
12 Dec 2024

Natera Announces Enrollment of First Patients in Sagittarius: a Randomized, Phase Iii Clinical Trial in Colon Cancer

THOMSON REUTERS
·
12 Dec 2024

Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer

Business Wire
·
12 Dec 2024

Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment

Business Wire
·
09 Dec 2024

Natera Aligns Executive Chairman’s Pay with Performance

TIPRANKS
·
07 Dec 2024

Strong Volume Growth Lifted Natera (NTRA) in Q3

Insider Monkey
·
03 Dec 2024

Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?

Insider Monkey
·
03 Dec 2024

Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology

Business Wire
·
02 Dec 2024

Natera Says Prospera Lung Test Gets Medicare Coverage for Single Lung Transplant Patients

MT Newswires Live
·
27 Nov 2024

BRIEF-Natera Announces Medicare Coverage For Prospera In Single Lung Transplant Recipients

Reuters
·
27 Nov 2024

Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients

THOMSON REUTERS
·
27 Nov 2024

Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients

Business Wire
·
27 Nov 2024

Piper Sandler Sticks to Their Buy Rating for Natera (NTRA)

TIPRANKS
·
26 Nov 2024

Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium

Business Wire
·
26 Nov 2024

Jury Awards Guardant Health $292.5M in False-Advertising Lawsuit Against Natera

Dow Jones
·
26 Nov 2024